Efficacy of immune checkpoint inhibitor plus chemotherapy in ARID1A-mutated advanced gastric cancer
Therapeutic Advances in Gastroenterology
Published online on May 15, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:ARID1A mutations are frequent in gastric cancer (GC) and may indicate an immune-active tumor microenvironment.Objectives:This study aimed to assess the efficacy of the immune checkpoint inhibitor (ICI) plus chemotherapy as first-line therapy in ...
Background:ARID1A mutations are frequent in gastric cancer (GC) and may indicate an immune-active tumor microenvironment.Objectives:This study aimed to assess the efficacy of the immune checkpoint inhibitor (ICI) plus chemotherapy as first-line therapy in ...